OsteoCentric Technologies Inc

OsteoCentric Technologies develops proprietary implant-to-bone interface technology designed to minimize bone damage during surgical implantation. The company's flagship product, UnifiMI® Interface Technology, applies minimally invasive surgery (MIS) principles to bone, preserving native bone architecture while maintaining immediate primary stability. The technology addresses two key clinical problems: sacrificed bone integrity and compromised implant stability resulting from conventional interference-fit insertion methods. UnifiMI uses a patented thread form design to cleanly prepare and preserve bone during implantation, creating a mechanically integrated interface that accelerates patient healing and recovery. OsteoCentric has acquired the Integrity SI-Fusion System™, expanding its orthopedic implant portfolio. The company's research foundation includes peer-reviewed publications demonstrating that conventional screw insertion in trabecular bone causes significant peri-implant damage, reducing mechanical and structural integrity. OsteoCentric serves orthopedic surgeons and surgical centers, with recognition in industry rankings (Top 10 Orthopedic Solution Companies 2021). Products are designed for both spinal and general orthopedic applications. The company operates with focus on regulatory compliance and clinical validation through published research.